Rishabh Jain, Medical Oncologist at AIIMS, shared a post on X:
“At EHA 2026, one phase 3 trial won every endpoint that controls the disease, then missed overall survival.
Issue 04 stamps it Watch, ranks the five that actually landed, and doubles a myeloma remission with a pill.”
Other articles featuring Dr. Jain on OncoDaily.